phosphatidylcholines has been researched along with cuprizone in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (cuprizone) | Trials (cuprizone) | Recent Studies (post-2010) (cuprizone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 825 | 1 | 629 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amor, S; Bazinet, RP; Hildebrand, KD; Kipp, M; Nyamoya, SD; Trépanier, MO | 1 |
| Dunstan, RW; Hamann, S; Hronowski, XL; Jandreski, L; Juhasz, P; Maganti, RJ; Wipke, BT; Zhang, X | 1 |
2 other study(ies) available for phosphatidylcholines and cuprizone
| Article | Year |
|---|---|
Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Female; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Myelin Sheath; Oleic Acid; Phosphatidylcholines; Postmortem Changes | 2018 |
Defining Changes in the Spatial Distribution and Composition of Brain Lipids in the Shiverer and Cuprizone Mouse Models of Myelin Disease.
Topics: Animals; Ceramides; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Immunohistochemistry; Lipid Metabolism; Male; Mice; Mice, Transgenic; Myelin Sheath; Phosphatidylcholines; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfoglycosphingolipids; White Matter | 2019 |